Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Research

Use of CAM among cancer patients

Results of a regional survey in Sweden

Authors: Mikael Källman, Stefan Bergström, Tobias Carlsson, Jacob Järås, Georg Holgersson, Johanna Hök Nordberg, Jonas Nilsson, Kathrin Wode, Michael Bergqvist

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

The use of complementary and alternative medicine (CAM) by patients is widespread. However, there is a lack of knowledge regarding the extent and details of patient CAM use in Sweden, especially in rural Sweden. The aim of this study was to estimate the extent and characteristics of CAM use among cancer patients in Region Gävleborg.

Methods

A total of 631 questionnaires were distributed to which 376 responses were registered, yielding a response rate of 59.6%. Questionnaires were distributed to oncology patients at their first visit for curative treatment at the Department of Oncology, Gävle Hospital. Palliative patients were recruited at their first visit and during enrollment in palliative outpatient care in their own homes. The characteristics of the respondents were presented with standard descriptive statistics. A multivariable logistic model was fitted to calculate odds ratios (ORs) and identify potential predictors (Age, Gender, Education, Diagnosis) of CAM use post-cancer diagnosis.

Results

54% of all participants reported lifetime CAM use, 34% reported CAM use post-diagnosis. The most common CAM methods used after diagnosis are vitamins, health food preparations, herbal teas, prayer and dietary methods. The most common source of information reported is family and friends. Almost 70% of those who used CAM after their diagnosis stated that they did not discuss their use with healthcare professionals. Most patients reported that they would like some CAM modalities to be offered within conventional care regardless of their own CAM use.

Conclusions

The use of CAM is common among patients with cancer in the region of Gävleborg, and previous studies show a similar use in Sweden in general. Based on the widespread use of CAM and patient interest in discussing CAM use with healthcare professionals, greater attention and focus should be placed on creating a basis for this dialogue. If we, as healthcare professionals, are to emphasise our commitment to providing patient-centred care, we must acknowledge that patients use CAM and are seeking a dialogue about CAM use in their care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hübner J, Beckmann M, Follmann M, Nothacker M, Prott FJ, Wörmann B. Complementary Medicine in the Treatment of Cancer Patients. Dtsch Arztebl Int. 2021;118(39):654–9.PubMedPubMedCentral Hübner J, Beckmann M, Follmann M, Nothacker M, Prott FJ, Wörmann B. Complementary Medicine in the Treatment of Cancer Patients. Dtsch Arztebl Int. 2021;118(39):654–9.PubMedPubMedCentral
3.
go back to reference Lopes CM, Dourado A, Oliveira R. Phytotherapy and Nutritional Supplements on Breast Cancer. Biomed Res Int. 2017;2017:1–42.CrossRef Lopes CM, Dourado A, Oliveira R. Phytotherapy and Nutritional Supplements on Breast Cancer. Biomed Res Int. 2017;2017:1–42.CrossRef
4.
go back to reference Bryan S, Zipp G, Breitkreuz D. The Effects of Mindfulness Meditation and Gentle Yoga on Spiritual Well-Being in Cancer Survivors: A Pilot Study. Altern Ther Health Med. 2021;27(3):32–8.PubMed Bryan S, Zipp G, Breitkreuz D. The Effects of Mindfulness Meditation and Gentle Yoga on Spiritual Well-Being in Cancer Survivors: A Pilot Study. Altern Ther Health Med. 2021;27(3):32–8.PubMed
5.
go back to reference Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How Many Cancer Patients Use Complementary and Alternative Medicine: A Systematic Review and Metaanalysis. Integr Cancer Ther. 2011;11(3):187–203.PubMedCrossRef Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How Many Cancer Patients Use Complementary and Alternative Medicine: A Systematic Review and Metaanalysis. Integr Cancer Ther. 2011;11(3):187–203.PubMedCrossRef
6.
go back to reference Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract. 2019;35:33–47.PubMedCrossRef Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract. 2019;35:33–47.PubMedCrossRef
7.
go back to reference Kristoffersen AE, Nilsen JV, Stub T, Nordberg JH, Wider B, Mora D, et al. se of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway. BMC Complement Med Ther. 2022;22(1):202.PubMedPubMedCentralCrossRef Kristoffersen AE, Nilsen JV, Stub T, Nordberg JH, Wider B, Mora D, et al. se of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway. BMC Complement Med Ther. 2022;22(1):202.PubMedPubMedCentralCrossRef
8.
go back to reference Wode K, Henriksson R, Sharp L, Stoltenberg A, Hok NJ. Cancer patients’ use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med. 2019;19(1):62.PubMedPubMedCentralCrossRef Wode K, Henriksson R, Sharp L, Stoltenberg A, Hok NJ. Cancer patients’ use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med. 2019;19(1):62.PubMedPubMedCentralCrossRef
9.
go back to reference Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63.PubMedCrossRef Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63.PubMedCrossRef
10.
go back to reference Härtel U, Volger E. Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland – Ergebnisse einer repräsentativen Bevölkerungsstudie. Complement Med Res. 2004;11(6):327–34.CrossRef Härtel U, Volger E. Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland – Ergebnisse einer repräsentativen Bevölkerungsstudie. Complement Med Res. 2004;11(6):327–34.CrossRef
11.
go back to reference Verhoef M, Balneaves L, Boon H, Vroegindewey A. Reasons for and Characteristics Associated With Complementary and Alternative Medicine Use Among Adult Cancer Patients: A Systematic Review. Integr Cancer Ther. 2016;4(4):274–86.CrossRef Verhoef M, Balneaves L, Boon H, Vroegindewey A. Reasons for and Characteristics Associated With Complementary and Alternative Medicine Use Among Adult Cancer Patients: A Systematic Review. Integr Cancer Ther. 2016;4(4):274–86.CrossRef
12.
go back to reference Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and Characteristics Associated With Complementary and Alternative Medicine Use Among Adult Cancer Patients: A Systematic Review. Integr Cancer Ther. 2005;4(4):274–86.PubMedCrossRef Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and Characteristics Associated With Complementary and Alternative Medicine Use Among Adult Cancer Patients: A Systematic Review. Integr Cancer Ther. 2005;4(4):274–86.PubMedCrossRef
13.
go back to reference Lettner S, Kessel KA, Combs SE. Complementary and alternative medicine in radiation oncology. Strahlenther Onkol. 2017;193(5):419–25.PubMedCrossRef Lettner S, Kessel KA, Combs SE. Complementary and alternative medicine in radiation oncology. Strahlenther Onkol. 2017;193(5):419–25.PubMedCrossRef
14.
go back to reference Guerra-Martín MD, Tejedor-Bueno MS, Correa-Casado M. Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review. Int J Environ Res Public Health. 2021;18(3):1017.PubMedPubMedCentralCrossRef Guerra-Martín MD, Tejedor-Bueno MS, Correa-Casado M. Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review. Int J Environ Res Public Health. 2021;18(3):1017.PubMedPubMedCentralCrossRef
15.
go back to reference Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol. 2018;36(25):2647–55.PubMedCrossRef Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, et al. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol. 2018;36(25):2647–55.PubMedCrossRef
16.
go back to reference Feize W, Meng L, Yanni L, Yuan L, Liqun J, Tong L, et al. A Randomized Controlled Study to Observe the Efficacy of External Treatment With a Traditional Chinese Medicine Herbal Ointment on Malignant Plural Effusion: Outcome Report and Design Review. Integr Cancer Ther. 2016;16(4):473–8.PubMedPubMedCentralCrossRef Feize W, Meng L, Yanni L, Yuan L, Liqun J, Tong L, et al. A Randomized Controlled Study to Observe the Efficacy of External Treatment With a Traditional Chinese Medicine Herbal Ointment on Malignant Plural Effusion: Outcome Report and Design Review. Integr Cancer Ther. 2016;16(4):473–8.PubMedPubMedCentralCrossRef
17.
go back to reference Mao H, Mao JJ, Guo M, Cheng K, Wei J, Shen X, et al. Effects of infrared laser moxibustion on cancer-related fatigue: A randomized, double-blind, placebo-controlled trial. Cancer. 2016;122(23):3667–72.PubMedCrossRef Mao H, Mao JJ, Guo M, Cheng K, Wei J, Shen X, et al. Effects of infrared laser moxibustion on cancer-related fatigue: A randomized, double-blind, placebo-controlled trial. Cancer. 2016;122(23):3667–72.PubMedCrossRef
18.
go back to reference Houzé B, El-Khatib H, Arbour C. Reprint of: Efficacy, tolerability, and safety of non-pharmacological therapies for chronic pain: An umbrella review on various CAM approaches. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87:307–21.PubMedCrossRef Houzé B, El-Khatib H, Arbour C. Reprint of: Efficacy, tolerability, and safety of non-pharmacological therapies for chronic pain: An umbrella review on various CAM approaches. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87:307–21.PubMedCrossRef
19.
go back to reference White A, Boon H, Alraek T, Lewith G, Liu J-P, Norheim A-J, et al. Reducing the risk of complementary and alternative medicine (CAM): Challenges and priorities. Eur J Integr Med. 2014;6(4):404–8.CrossRef White A, Boon H, Alraek T, Lewith G, Liu J-P, Norheim A-J, et al. Reducing the risk of complementary and alternative medicine (CAM): Challenges and priorities. Eur J Integr Med. 2014;6(4):404–8.CrossRef
20.
go back to reference Svedlund E, Larsson M, Hägerkvist R. Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007–15: Report from the Medical Products Agency. Drugs - Real World Outcomes. 2017;4(2):119–25.PubMedPubMedCentralCrossRef Svedlund E, Larsson M, Hägerkvist R. Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007–15: Report from the Medical Products Agency. Drugs - Real World Outcomes. 2017;4(2):119–25.PubMedPubMedCentralCrossRef
21.
go back to reference Jacobsson I, Jönsson AK, Gerdén B, Hägg S. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden. Pharmacoepidemiol Drug Saf. 2009;18(11):1039–47.PubMedCrossRef Jacobsson I, Jönsson AK, Gerdén B, Hägg S. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden. Pharmacoepidemiol Drug Saf. 2009;18(11):1039–47.PubMedCrossRef
22.
go back to reference Wardle J, Lui C-W, Adams J. Complementary and Alternative Medicine in Rural Communities: Current Research and Future Directions. J Rural Health. 2012;28(1):101–12.PubMedCrossRef Wardle J, Lui C-W, Adams J. Complementary and Alternative Medicine in Rural Communities: Current Research and Future Directions. J Rural Health. 2012;28(1):101–12.PubMedCrossRef
23.
go back to reference Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE. Attitudes and knowledge about direct and indirect risks among conventional and complementary health care providers in cancer care. BMC Complement Altern Med. 2018;18(1):44.PubMedPubMedCentralCrossRef Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE. Attitudes and knowledge about direct and indirect risks among conventional and complementary health care providers in cancer care. BMC Complement Altern Med. 2018;18(1):44.PubMedPubMedCentralCrossRef
24.
go back to reference Thomford NE, Dzobo K, Chopera D, Wonkam A, Maroyi A, Blackhurst D, et al. In Vitro Reversible and Time-Dependent CYP450 Inhibition Profiles of Medicinal Herbal Plant Extracts Newbouldia laevis and Cassia abbreviata: Implications for Herb-Drug Interactions. Molecules. 2016;21(7):891.PubMedPubMedCentralCrossRef Thomford NE, Dzobo K, Chopera D, Wonkam A, Maroyi A, Blackhurst D, et al. In Vitro Reversible and Time-Dependent CYP450 Inhibition Profiles of Medicinal Herbal Plant Extracts Newbouldia laevis and Cassia abbreviata: Implications for Herb-Drug Interactions. Molecules. 2016;21(7):891.PubMedPubMedCentralCrossRef
25.
go back to reference Hietala M, Henningson M, Ingvar C, Jönsson P-E, Rose C, Jernström H. Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden. Acta Oncol. 2011;50(1):134–43.PubMedCrossRef Hietala M, Henningson M, Ingvar C, Jönsson P-E, Rose C, Jernström H. Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden. Acta Oncol. 2011;50(1):134–43.PubMedCrossRef
26.
go back to reference Matthews MK. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology. 1998;50(6):1933.PubMedCrossRef Matthews MK. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology. 1998;50(6):1933.PubMedCrossRef
27.
go back to reference Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB. Coma in a patient with Alzheimer’s disease taking low dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry. 2000;68(5):679–80.PubMedPubMedCentralCrossRef Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB. Coma in a patient with Alzheimer’s disease taking low dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry. 2000;68(5):679–80.PubMedPubMedCentralCrossRef
28.
go back to reference Clairet AL, Boiteux-Jurain M, Curtit E, Jeannin M, Gérard B, Nerich V, et al. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review. Med Oncol. 2019;36(5):45.PubMedCrossRef Clairet AL, Boiteux-Jurain M, Curtit E, Jeannin M, Gérard B, Nerich V, et al. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review. Med Oncol. 2019;36(5):45.PubMedCrossRef
29.
go back to reference Frenkel M, Ben-Arye E, Cohen L. Communication in Cancer Care: Discussing Complementary and Alternative Medicine. Integr Cancer Ther. 2010;9(2):177–85.PubMedCrossRef Frenkel M, Ben-Arye E, Cohen L. Communication in Cancer Care: Discussing Complementary and Alternative Medicine. Integr Cancer Ther. 2010;9(2):177–85.PubMedCrossRef
30.
go back to reference Juraskova I, Hegedus L, Butow P, Smith A, Schofield P. Discussing Complementary Therapy Use With Early-Stage Breast Cancer Patients: Exploring the Communication Gap. Integr Cancer Ther. 2010;9(2):168–76.PubMedCrossRef Juraskova I, Hegedus L, Butow P, Smith A, Schofield P. Discussing Complementary Therapy Use With Early-Stage Breast Cancer Patients: Exploring the Communication Gap. Integr Cancer Ther. 2010;9(2):168–76.PubMedCrossRef
31.
go back to reference King N, Balneaves LG, Levin GT, Nguyen T, Nation JG, Card C, et al. Surveys of Cancer Patients and Cancer Health Care Providers Regarding Complementary Therapy Use, Communication, and Information Needs. Integr Cancer Ther. 2015;14(6):515–24.PubMedCrossRef King N, Balneaves LG, Levin GT, Nguyen T, Nation JG, Card C, et al. Surveys of Cancer Patients and Cancer Health Care Providers Regarding Complementary Therapy Use, Communication, and Information Needs. Integr Cancer Ther. 2015;14(6):515–24.PubMedCrossRef
32.
go back to reference Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE, Musial F, et al. Perception of risk and communication among conventional and complementary health care providers involving cancer patients’ use of complementary therapies: a literature review. BMC Complement Altern Med. 2016;16(1):353.PubMedPubMedCentralCrossRef Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE, Musial F, et al. Perception of risk and communication among conventional and complementary health care providers involving cancer patients’ use of complementary therapies: a literature review. BMC Complement Altern Med. 2016;16(1):353.PubMedPubMedCentralCrossRef
33.
go back to reference Adams J, Sibbritt D, Lui C-W. The urban-rural divide in complementary and alternative medicine use: a longitudinal study of 10,638 women. BMC Complement Altern Med. 2011;11(1):2.PubMedPubMedCentralCrossRef Adams J, Sibbritt D, Lui C-W. The urban-rural divide in complementary and alternative medicine use: a longitudinal study of 10,638 women. BMC Complement Altern Med. 2011;11(1):2.PubMedPubMedCentralCrossRef
37.
go back to reference Vaccarella S, Georges D, Bray F, Ginsburg O, Charvat H, Martikainen P, et al. Socioeconomic inequalities in cancer mortality between and within countries in Europe: A population-based study. The Lancet Regional Health - Europe. 2022:100551. Vaccarella S, Georges D, Bray F, Ginsburg O, Charvat H, Martikainen P, et al. Socioeconomic inequalities in cancer mortality between and within countries in Europe: A population-based study. The Lancet Regional Health - Europe. 2022:100551.
39.
go back to reference Nilsson J, Kallman M, Ostlund U, Holgersson G, Bergqvist M, Bergstrom S. The Use of Complementary and Alternative Medicine in Scandinavia. Anticancer Res. 2016;36(7):3243–51.PubMed Nilsson J, Kallman M, Ostlund U, Holgersson G, Bergqvist M, Bergstrom S. The Use of Complementary and Alternative Medicine in Scandinavia. Anticancer Res. 2016;36(7):3243–51.PubMed
40.
go back to reference Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61(15):2163–75.PubMedCrossRef Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61(15):2163–75.PubMedCrossRef
41.
go back to reference Nissen N, Lunde A, Pedersen CG, Johannessen H. The use of complementary and alternative medicine after the completion of hospital treatment for colorectal cancer: findings from a questionnaire study in Denmark. BMC Complement Altern Med. 2014;14:388.PubMedPubMedCentralCrossRef Nissen N, Lunde A, Pedersen CG, Johannessen H. The use of complementary and alternative medicine after the completion of hospital treatment for colorectal cancer: findings from a questionnaire study in Denmark. BMC Complement Altern Med. 2014;14:388.PubMedPubMedCentralCrossRef
42.
go back to reference Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, et al. Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complement Ther Clin Pract. 2005;11(2):105–10.PubMedCrossRef Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, et al. Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complement Ther Clin Pract. 2005;11(2):105–10.PubMedCrossRef
43.
go back to reference Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM, et al. Determinants of the Use of Complementary Therapies by Patients With Cancer. J Clin Oncol. 2001;19(9):2439–48.PubMedCrossRef Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM, et al. Determinants of the Use of Complementary Therapies by Patients With Cancer. J Clin Oncol. 2001;19(9):2439–48.PubMedCrossRef
44.
go back to reference Engdal S, Steinsbekk A, Klepp O, Nilsen OG. Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer. 2008;16(7):763–9.PubMedCrossRef Engdal S, Steinsbekk A, Klepp O, Nilsen OG. Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer. 2008;16(7):763–9.PubMedCrossRef
45.
go back to reference Helyer LK, Chin S, Chui BK, Fitzgerald B, Verma S, Rakovitch E, et al. The use of complementary and alternative medicines among patients with locally advanced breast cancer–a descriptive study. BMC Cancer. 2006;6:39.PubMedPubMedCentralCrossRef Helyer LK, Chin S, Chui BK, Fitzgerald B, Verma S, Rakovitch E, et al. The use of complementary and alternative medicines among patients with locally advanced breast cancer–a descriptive study. BMC Cancer. 2006;6:39.PubMedPubMedCentralCrossRef
46.
go back to reference Bjerså K, Stener Victorin E, Fagevik OM. Knowledge about complementary, alternative and integrative medicine (CAM) among registered health care providers in Swedish surgical care: a national survey among university hospitals. BMC Complement Altern Med. 2012;12:42.PubMedPubMedCentralCrossRef Bjerså K, Stener Victorin E, Fagevik OM. Knowledge about complementary, alternative and integrative medicine (CAM) among registered health care providers in Swedish surgical care: a national survey among university hospitals. BMC Complement Altern Med. 2012;12:42.PubMedPubMedCentralCrossRef
47.
48.
go back to reference Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63.PubMedCrossRef Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63.PubMedCrossRef
49.
go back to reference Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides (New York, NY : 1980). 2006;27(6):1173–8. Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides (New York, NY : 1980). 2006;27(6):1173–8.
50.
go back to reference Smithson J, Britten N, Paterson C, Lewith G, Evans M. The experience of using complementary therapies after a diagnosis of cancer: A qualitative synthesis. Health. 2017;16(1):19–39.CrossRef Smithson J, Britten N, Paterson C, Lewith G, Evans M. The experience of using complementary therapies after a diagnosis of cancer: A qualitative synthesis. Health. 2017;16(1):19–39.CrossRef
51.
go back to reference Hök J, Tishelman C, Ploner A, Forss A, Falkenberg T. Mapping patterns of complementary and alternative medicine use in cancer: An explorative cross-sectional study of individuals with reported positive “exceptional” experiences. BMC Complementary and Alternative Medicine. 2008;8(1):48. undefinedPubMedPubMedCentralCrossRef Hök J, Tishelman C, Ploner A, Forss A, Falkenberg T. Mapping patterns of complementary and alternative medicine use in cancer: An explorative cross-sectional study of individuals with reported positive “exceptional” experiences. BMC Complementary and Alternative Medicine. 2008;8(1):48. undefinedPubMedPubMedCentralCrossRef
52.
go back to reference Buckner CA, Lafrenie RM, Dénommée JA, Caswell JM, Want DA. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018;25(4):e275–81.PubMedPubMedCentralCrossRef Buckner CA, Lafrenie RM, Dénommée JA, Caswell JM, Want DA. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018;25(4):e275–81.PubMedPubMedCentralCrossRef
Metadata
Title
Use of CAM among cancer patients
Results of a regional survey in Sweden
Authors
Mikael Källman
Stefan Bergström
Tobias Carlsson
Jacob Järås
Georg Holgersson
Johanna Hök Nordberg
Jonas Nilsson
Kathrin Wode
Michael Bergqvist
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-03876-2

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue